Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
54 hedge funds and large institutions have $31.4M invested in Applied Genetic Technologies Corporation in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 13 closing their positions.
5% more capital invested
Capital invested by funds: $30M → $31.4M (+$1.38M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 62 → 54 (-8)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$456K |
| 2 |
BlackRock
New York
|
-$330K |
| 3 |
Millennium Management
New York
|
-$328K |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$281K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$241K |
AGTC Hedge Fund Activity: Q1 2018 in Review
54 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2018, worth a combined $31.4M — up 4.6% from $30M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of AGTC and 6 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 13 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $757K. The largest seller was Fidelity Investments, cutting an estimated $456K.
- 54 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2018, down from 62 in Q4 2017.
- Funds reported $31.4M of Applied Genetic Technologies Corporation stock for Q1 2018, up 4.6% quarter-over-quarter.
- 6 funds opened new Applied Genetic Technologies Corporation positions in Q1 2018 and 13 closed out, a net change of -7 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q1 2018 was Point72 Asset Management, an estimated $757K added.
- The largest Applied Genetic Technologies Corporation seller in Q1 2018 was Fidelity Investments, an estimated $456K sold.
Based on aggregated 13F filings for Q1 2018.